Radiofrequency Lesioning for Hemidystonia: A Systematic Review and Meta-Analysis with Individual Patient Data Arif Abdulbaki, Amr Jijakli, Ali Savas, Angelo Rafael Cunha de Azevedo, Erich Talamoni Fonoff, Paresh K. Doshi, Joachim K. Krauss Stereotactic and Functional Neurosurgery, 2026 Introduction: Radiofrequency lesioning (RL) had been a mainstay in functional neurosurgery for dystonic movement disorders before the widespread adoption of deep brain stimulation. Outcomes of RL in hemidystonia have varied. This review provides a systematic analysis of RL for hemidystonia and evaluates the spectrum of clinical outcome. Methods: A systematic literature review was performed according to PRISMA guidelines in PubMed, Embase, and Web of Science using customized software (UiPath, NY) to identify all cohort studies, case series, and case reports on patients with hemidystonia treated with RF. Manuscripts were automatically searched for the term “hemidystonia.” The selected manuscripts were then manually screened. Detailed information from two recent multi-patient studies was added. Outcome was assessed according to changes in rating scales or by the reported clinical descriptions. Clinical improvement then was classified as follows: (0) no improvement, (I) mild, (II) moderate, (III) marked improvement. Results: Twenty-eight studies with individual patient data were included, totaling 101 cases published between 1962 and 2024. Thalamotomy/subthalamic region lesioning was performed in 80 cases, pallidotomy in 16, and both in 5. At the last follow-up, the overall distribution of clinical improvement was statistically significant (p = 0.0004) where the majority of patients (44.09%) showed moderate improvement. No significant differences were found between targets or etiologies, though patients with traumatic brain injury tended to fare worse. A significant negative linear correlation was found between the degree of improvement and age at surgery. Conclusion: With advancements in targeting and technology, RL may represent a viable treatment option for selected patients with hemidystonia. However, given the current evidence limitations, prospective studies with standardized outcome assessments are needed to better characterize response variability and identify prognostic factors.
Efficacy of deep brain stimulation of the subthalamic nucleus versus globus pallidus internus on sensory complaints Maria Gabriela S. Ghilardi, Ana Carolina P. Campos, Rubens G. Cury, Raquel C. R. Martinez, Rosana L. Pagano, Erich T. Fonoff Npj Parkinson S Disease, 2024 Pain control after deep brain stimulation (DBS) in Parkinson’s disease (PD) remains unclear. Following six months, subthalamic (STN)-DBS reduced sensory complaints related to parkinsonism and bodily discomfort, increasing central beta-endorphin level. Pallidal GPi-DBS decreased bodily discomfort and beta-endorphin levels. Unexplained pain by other conditions and bodily discomfort were negatively correlated with beta-endorphin levels. Thus, DBS regulates central opioids, and prioritizing STN is important for PD patients with significant sensory complications.
Preoperative Cortical Mapping for Brain Tumor Surgery Using Navigated Transcranial Stimulation: Analysis of Accuracy Wellingson Silva Paiva, Erich Talamoni Fonoff, Rhuann Pontes dos Santos Silva, Lucas Schiavao, André Russowsky Brunoni, César Cimonari de Almeida, Carlos Carlotti Júnior Brain Sciences, 2024 Transcranial magnetic stimulation (TMS) represents a distinctive technique for non-invasive brain stimulation. Recent advancements in image processing have enabled the enhancement of TMS by integrating magnetic resonance imaging (MRI) modalities with TMS via a neuronavigation system. The aim of this study is to assess the efficacy of navigated TMS for cortical mapping in comparison to surgical mapping using direct electrical stimulation (DES). This study involved 30 neurosurgical procedures for tumors located in or adjacent to the precentral gyrus. The DES points were compared with TMS responses based on the original distances of vectorial modules. There was a notable similarity in the points obtained from the two mapping methods. The distances between the geometric centers of TMS and DCS were 4.85 ± 1.89 mm. A strong correlation was identified between these vectorial points (r = 0.901, p < 0.001). The motor threshold in TMS was highest in the motor cortex adjacent to the tumor compared to the normal cortex (p < 0.001). Patients with deficits exhibited excellent accuracy in both methods. In view of this, TMS demonstrated reliable and precise application in brain mapping, which is a promising method for preoperative functional mapping in motor cortex tumor surgery.
A Pragmatic Review on Spinal Cord Stimulation Therapy for Parkinson's Disease Gait Related Disorders: Gaps and Controversies Victor S. Hvingelby, Rafael B. Carra, Miriam H. Terkelsen, Clement Hamani, Tamine Capato, Zuzana Košutzká, Joachim K. Krauss, Elena Moro, Nicola Pavese, Rubens G. Cury Movement Disorders Clinical Practice, 2024 BackgroundParkinson's Disease (PD) is a progressive neurological disorder that results in potentially debilitating mobility deficits. Recently, spinal cord stimulation (SCS) has been proposed as a novel therapy for PD gait disorders. The highest levels of evidence remain limited for SCS.ObjectivesIn this systematic review and narrative synthesis, the literature was searched using combinations of key phrases indicating spinal cord stimulation and PD.MethodsWe included pre‐clinical studies and all published clinical trials, case reports, conference abstracts as well as protocols for ongoing clinical trials. Additionally, we included trials of SCS applied to atypical parkinsonism.ResultsA total of 45 human studies and trials met the inclusion criteria. Based on the narrative synthesis, a number of knowledge gaps and future avenues of potential research were identified. This review demonstrated that evidence for SCS is currently not sufficient to recommend it as an evidence‐based therapy for PD related gait disorders. There remain challenges and significant barriers to widespread implementation, including issues regarding patient selection, effective outcome selection, stimulation location and mode, and in programming parameter optimization. Results of early randomized controlled trials are currently pending. SCS is prone to placebo, lessebo and nocebo as well as blinding effects which may impact interpretation of outcomes, particularly when studies are underpowered.ConclusionTherapies such as SCS may build on current evidence and be shown to improve specific gait features in PD. Early negative trials should be interpreted with caution, as more evidence will be required to develop effective methodologies in order to drive clinical outcomes.
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study Ana Westenberger, Volha Skrahina, Tatiana Usnich, Christian Beetz, Eva-Juliane Vollstedt, Björn-Hergen Laabs, Jefri J Paul, Filipa Curado, Snezana Skobalj, Hanaa Gaber, Maria Olmedillas, Xenia Bogdanovic, Najim Ameziane, Nathalie Schell, Jan Olav Aasly, Mitra Afshari, Pinky Agarwal, Jason Aldred, Fernando Alonso-Frech, Roderick Anderson, Rui Araújo, David Arkadir, Micol Avenali, Mehmet Balal, Sandra Benizri, Sagari Bette, Perminder Bhatia, Michael Bonello, Pedro Braga-Neto, Sarah Brauneis, Francisco Eduardo Costa Cardoso, Francesco Cavallieri, Joseph Classen, Lisa Cohen, Della Coletta, David Crosiers, Paskal Cullufi, Khashayar Dashtipour, Meltem Demirkiran, Patricia de Carvalho Aguiar, Anna De Rosa, Ruth Djaldetti, Okan Dogu, Maria Gabriela dos Santos Ghilardi, Carsten Eggers, Bulent Elibol, Aaron Ellenbogen, Sibel Ertan, Giorgio Fabiani, Björn H Falkenburger, Simon Farrow, Tsviya Fay-Karmon, Gerald J Ferencz, Erich Talamoni Fonoff, Yara Dadalti Fragoso, Gençer Genç, Arantza Gorospe, Francisco Grandas, Doreen Gruber, Mark Gudesblatt, Tanya Gurevich, Johann Hagenah, Hasmet A Hanagasi, Sharon Hassin-Baer, Robert A Hauser, Jorge Hernández-Vara, Birgit Herting, Vanessa K Hinson, Elliot Hogg, Michele T Hu, Eduardo Hummelgen, Kelly Hussey, Jon Infante, Stuart H Isaacson, Serge Jauma, Natalia Koleva-Alazeh, Gregor Kuhlenbäumer, Andrea Kühn, Irene Litvan, Lydia López-Manzanares, McKenzie Luxmore, Sujeena Manandhar, Veronique Marcaud, Katerina Markopoulou, Connie Marras, Mark McKenzie, Michele Matarazzo, Marcelo Merello, Brit Mollenhauer, John C Morgan, Stephen Mullin, Thomas Musacchio, Bennett Myers, Anna Negrotti, Anette Nieves, Zeev Nitsan, Nader Oskooilar, Özgür Öztop-Çakmak, Gian Pal, Nicola Pavese, Antonio Percesepe, Tommaso Piccoli, Carolina Pinto de Souza, Tino Prell, Mark Pulera, Jason Raw, Kathrin Reetz, Johnathan Reiner, David Rosenberg, Marta Ruiz-Lopez, Javier Ruiz Martinez, Esther Sammler, Bruno Lopes Santos-Lobato, Rachel Saunders-Pullman, Ilana Schlesinger, Christine M Schofield, Artur F Schumacher-Schuh, Burton Scott, Ángel Sesar, Stuart J Shafer, Ray Sheridan, Monty Silverdale, Rani Sophia, Mariana Spitz, Pantelis Stathis, Fabrizio Stocchi, Michele Tagliati, Yen F Tai, Annelies Terwecoren, Sven Thonke, Lars Tönges, Giulia Toschi, Vitor Tumas, Peter Paul Urban, Laura Vacca, Wim Vandenberghe, Enza Maria Valente, Franco Valzania, Lydia Vela-Desojo, Caroline Weill, David Weise, Joanne Wojcieszek, Martin Wolz, Gilad Yahalom, Gul Yalcin-Cakmakli, Simone Zittel, Yair Zlotnik, Krishna K Kandaswamy, Alexander Balck, Henrike Hanssen, Max Borsche, Lara M Lange, Ilona Csoti, Katja Lohmann, Meike Kasten, Norbert Brüggemann, Arndt Rolfs, Christine Klein, Peter Bauer Brain, 2024 Estimates of the spectrum and frequency of pathogenic variants in Parkinson’s disease (PD) in different populations are currently limited and biased. Furthermore, although therapeutic modification of several genetic targets has reached the clinical trial stage, a major obstacle in conducting these trials is that PD patients are largely unaware of their genetic status and, therefore, cannot be recruited. Expanding the number of investigated PD-related genes and including genes related to disorders with overlapping clinical features in large, well-phenotyped PD patient groups is a prerequisite for capturing the full variant spectrum underlying PD and for stratifying and prioritizing patients for gene-targeted clinical trials. The Rostock Parkinson’s disease (ROPAD) study is an observational clinical study aiming to determine the frequency and spectrum of genetic variants contributing to PD in a large international cohort. We investigated variants in 50 genes with either an established relevance for PD or possible phenotypic overlap in a group of 12 580 PD patients from 16 countries [62.3% male; 92.0% White; 27.0% positive family history (FH+), median age at onset (AAO) 59 years] using a next-generation sequencing panel. Altogether, in 1864 (14.8%) ROPAD participants (58.1% male; 91.0% White, 35.5% FH+, median AAO 55 years), a PD-relevant genetic test (PDGT) was positive based on GBA1 risk variants (10.4%) or pathogenic/likely pathogenic variants in LRRK2 (2.9%), PRKN (0.9%), SNCA (0.2%) or PINK1 (0.1%) or a combination of two genetic findings in two genes (∼0.2%). Of note, the adjusted positive PDGT fraction, i.e. the fraction of positive PDGTs per country weighted by the fraction of the population of the world that they represent, was 14.5%. Positive PDGTs were identified in 19.9% of patients with an AAO ≤ 50 years, in 19.5% of patients with FH+ and in 26.9% with an AAO ≤ 50 years and FH+. In comparison to the idiopathic PD group (6846 patients with benign variants), the positive PDGT group had a significantly lower AAO (4 years, P = 9 × 10−34). The probability of a positive PDGT decreased by 3% with every additional AAO year (P = 1 × 10−35). Female patients were 22% more likely to have a positive PDGT (P = 3 × 10−4), and for individuals with FH+ this likelihood was 55% higher (P = 1 × 10−14). About 0.8% of the ROPAD participants had positive genetic testing findings in parkinsonism-, dystonia/dyskinesia- or dementia-related genes. In the emerging era of gene-targeted PD clinical trials, our finding that ∼15% of patients harbour potentially actionable genetic variants offers an important prospect to affected individuals and their families and underlines the need for genetic testing in PD patients. Thus, the insights from the ROPAD study allow for data-driven, differential genetic counselling across the spectrum of different AAOs and family histories and promote a possible policy change in the application of genetic testing as a routine part of patient evaluation and care in PD.
A Microdevice in a Submicron CMOS for Closed-Loop Deep-Brain Stimulation (CLDBS) Tiago Matheus Nordi, Rodrigo Gounella, Marcio L. M. Amorim, Maximiliam Luppe, João Navarro Soares Junior, Joao L. Afonso, Vitor Monteiro, Jose A. Afonso, Erich Talamoni Fonoff, Eduardo Colombari, João Paulo Carmo Journal of Low Power Electronics and Applications, 2024 Deep-brain stimulation (DBS) is a highly effective and safe medical treatment that improves the lives of patients with a wide range of neurological and psychiatric diseases. It has been established as a first-line tool in the treatment of these conditions for the past two decades. Closed-loop deep-brain stimulation (CLDBS) advances this tool further by automatically adjusting the stimulation parameters in real time based on the brain’s response. In this context, this paper presents a low-noise amplifier (LNA) and a neurostimulator circuit fabricated using the low-power/low-voltage 65 nm CMOS process from TSMC. The circuits are specifically designed for implantable applications. To achieve the best tradeoff between input-referred noise and power consumption, metaheuristic algorithms were employed to determine and optimize the dimensions of the LNA devices during the design phase. Measurement results showed that the LNA had a gain of 41.2 dB; a 3 dB bandwidth spanning over three decades, from 1.5 Hz to 11.5 kHz; a power consumption of 5.9 µW; and an input-referred noise of 3.45 µVRMS, from 200 Hz to 11.5 kHz. The neurostimulator circuit is a programmable Howland current pump. Measurements have shown its capability to generate currents with arbitrary shapes and ranging from −325 µA to +318 µA. Simulations indicated a quiescent power consumption of 0.13 µW, with zero neurostimulation current. Both the LNA and the neurostimulator circuits are supplied with a 1.2 V voltage and occupy a microdevice area of 145 µm × 311 µm and 88 µm × 89 µm, respectively, making them suitable for implantation in applications involving closed-loop deep-brain stimulation.
Microendoscopic Intradural Cordotomy for the Treatment of Cancer Pain Neuroendoscopy and Interventional Pain Medicine Volume 2 Endoscopy and Fetoscopy Techniques for the Brain and Neuroaxis, 2024
Trigeminal Tractotomies and Nucleotomies Neuroendoscopy and Interventional Pain Medicine Volume 2 Endoscopy and Fetoscopy Techniques for the Brain and Neuroaxis, 2024
Non-motor effects of deep brain stimulation in Parkinson's disease motor subtypes Stefanie T. Jost, Agni Konitsioti, Philipp A. Loehrer, Keyoumars Ashkan, Alexandra Rizos, Anna Sauerbier, Maria Gabriela dos Santos Ghilardi, Franz Rosenkranz, Lena Strobel, Alexandra Gronostay, Michael T. Barbe, Julian Evans, Veerle Visser-Vandewalle, Christopher Nimsky, Gereon R. Fink, Monty Silverdale, Rubens G. Cury, Erich T. Fonoff, Angelo Antonini, K. Ray Chaudhuri, Lars Timmermann, Pablo Martinez-Martin, Haidar S. Dafsari Parkinsonism and Related Disorders, 2023
Charge-Pump Circuit in 65nm CMOS for Neural Stimulation on Deep-Brain Stimulation Tiago Mateus Nordi, V. M. Barbosa, R. H. Gounella, Godfred Asan, Maximiliam Luppe, Joao Navarro, Soares Junior, J. P. Carmo, Erich Talamoni Fonoff, Eduardo Colombari 36th Conference on Design of Circuits and Integrated Systems Dcis 2021, 2021
Increased Anxiety-Like Behavior in the Acute Phase of a Preclinical Model of Periodontal Disease Bruna Luiza Roim Varotto, Raquel Chacon Ruiz Martinez, Flavia Venetucci Gouveia, Geiza Fernanda Antunes, Gisele Maria de Campos Fabri, Gerson Ballester, Reynaldo Antequera, Silvia Regina Dowgan Tesseroli de Siqueira, Erich Talamoni Fonoff, Manoel Jacobsen Teixeira, José Tadeu Tesseroli de Siqueira Frontiers in Neurology, 2020
Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease Haidar S. Dafsari, Maria Gabriela dos Santos Ghilardi, Veerle Visser-Vandewalle, Alexandra Rizos, Keyoumars Ashkan, Monty Silverdale, Julian Evans, Raquel C.R. Martinez, Rubens G. Cury, Stefanie T. Jost, Michael T. Barbe, Gereon R. Fink, Angelo Antonini, K. Ray-Chaudhuri, Pablo Martinez-Martin, Erich Talamoni Fonoff, Lars Timmermann Brain Stimulation, 2020
The ansa subthalamica as a substrate for DBS-induced manic symptoms Flavia V. Gouveia, Pedro Gomes de Alvarenga, Eduardo J.L. Alho, Rachel E.S. Takahashi, Ruth Franco, Antonio Carlos Lopes, Erich T. Fonoff, Durval Damiani, Manoel J. Teixeira, Euripides C. Miguel, Clement Hamani Brain Stimulation, 2020
The Ansa Subthalamica: A Neglected Fiber Tract Eduardo Joaquim Lopes Alho, Ana Tereza Di Lorenzo Alho, Andreas Horn, Maria da Graça M. Martin, Brian L. Edlow, Bruce Fischl, József Nagy, Erich T. Fonoff, Clement Hamani, Helmut Heinsen Movement Disorders, 2020
Non-motor outcomes depend on location of neurostimulation in Parkinson's disease Jan Niklas Petry-Schmelzer, Max Krause, Till A Dembek, Andreas Horn, Julian Evans, Keyoumars Ashkan, Alexandra Rizos, Monty Silverdale, Wibke Schumacher, Carolin Sack, Philipp A Loehrer, Gereon R Fink, Erich T Fonoff, Pablo Martinez-Martin, Angelo Antonini, Michael T Barbe, Veerle Visser-Vandewalle, K Ray-Chaudhuri, Lars Timmermann, Haidar S Dafsari, EUROPAR, the IPMDS Non-Motor PD Study Group, Kallol Ray-Chaudhuri, Angelo Antonini, Pablo Martinez-Martin, Per Odin, Anette Schrag, Daniel Weintraub, Paolo Barone, David J Brooks, Richard G Brown, Peter Jenner, B Jeon, Kelly Lyons, Nicola Pavese, Marios Politis, Ronald B Postuma, Anthony Schapira, Fabrizio Stocchi, Lars Timmermann, Yoshio Tsuboi, Alexandra Rizos, Anna Sauerbier Brain, 2019
Amygdala and Hypothalamus: Historical Overview with Focus on Aggression Flavia Venetucci Gouveia, Clement Hamani, Erich Talamoni Fonoff, Helena Brentani, Eduardo Joaquim Lopes Alho, Rosa Magaly Campêlo Borba de Morais, Aline Luz de Souza, Sérgio Paulo Rigonatti, Raquel C R Martinez Clinical Neurosurgery, 2019
EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease Haidar S. Dafsari, Pablo Martinez‐Martin, Alexandra Rizos, Maja Trost, Maria Gabriela dos Santos Ghilardi, Prashanth Reddy, Anna Sauerbier, Jan Niklas Petry‐Schmelzer, Milica Kramberger, Robbert W. K. Borgemeester, Michael T. Barbe, Keyoumars Ashkan, Monty Silverdale, Julian Evans, Per Odin, Erich Talamoni Fonoff, Gereon R. Fink, Tove Henriksen, Georg Ebersbach, Zvezdan Pirtošek, Veerle Visser‐Vandewalle, Angelo Antonini, Lars Timmermann, K. Ray Chaudhuri, on behalf of EUROPAR, the International Parkinson, Movement Disorders Society Non‐Motor Parkinson's Disease Study Group Movement Disorders, 2019
Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder Euripedes C. Miguel, Antonio C. Lopes, Nicole C. R. McLaughlin, Georg Norén, André F. Gentil, Clement Hamani, Roseli G. Shavitt, Marcelo C. Batistuzzo, Edoardo F. Q. Vattimo, Miguel Canteras, Antonio De Salles, Alessandra Gorgulho, João Victor Salvajoli, Erich Talamoni Fonoff, Ian Paddick, Marcelo Q. Hoexter, Christer Lindquist, Suzanne N. Haber, Benjamin D. Greenberg, Sameer A. Sheth Molecular Psychiatry, 2019
Spinal cord stimulation for freezing of gait: From bench to bedside Erich Talamoni Fonoff, Andrea C. de Lima-Pardini, Daniel Boari Coelho, Bernardo Assumpção Monaco, Birajara Machado, Carolina Pinto de Souza, Maria Gabriela dos Santos Ghilardi, Clement Hamani Frontiers in Neurology, 2019
Effects of Subthalamic Stimulation on Olfactory Function in Parkinson Disease Rubens Gisbert Cury, Margarete de Jesus Carvalho, Fernando Jeyson Lopez Lasteros, Alice Estevo Dias, Maria Gabriela dos Santos Ghilardi, Anderson Rodrigues Brandão Paiva, Artur Martins Coutinho, Carlos Alberto Buchpiguel, Manoel J. Teixeira, Egberto Reis Barbosa, Erich Talamoni Fonoff World Neurosurgery, 2018
Lateral hypothalamic activity indicates hunger and satiety states in humans Omid Talakoub, Raquel R. Paiva, Matija Milosevic, Marcelo Q. Hoexter, Ruth Franco, Eduardo Alho, Jessie Navarro, José F. Pereira, Milos R. Popovic, Cary Savage, Antonio C. Lopes, Pedro Alvarenga, Durval Damiani, Manoel J. Teixeira, Euripides C. Miguel, Erich T. Fonoff, Marcelo C. Batistuzzo, Clement Hamani Annals of Clinical and Translational Neurology, 2017
Dramatic improvement of tardive dyskinesia movements by inline skating Sara Carvalho Barbosa Casagrande, Rubens Gisbert Cury, Andrea Cristina de Lima-Pardini, Daniel Boari Coelho, Carolina de Oliveira Souza, Maria Gabriela dos Santos Ghilardi, Laura Silveira-Moriyama, Luis Augusto Teixeira, Egberto Reis Barbosa, Erich Talamoni Fonoff Neurology, 2017
Peduncolopontine DBS improves balance in progressive supranuclear palsy: Instrumental analysis Carolina de Oliveira Souza, Andrea Cristina de Lima-Pardini, Daniel Boari Coelho, Rachael Brant Machado, Eduardo Joaquim Lopes Alho, Ana Tereza Di Lorenzo Alho, Luis Augusto Teixeira, Manoel Jacobsen Teixeira, Egberto Reis Barbosa, Erich Talamoni Fonoff Clinical Neurophysiology, 2016
DBS for obesity Ruth Franco, Erich Fonoff, Pedro Alvarenga, Antonio Lopes, Euripides Miguel, Manoel Teixeira, Durval Damiani, Clement Hamani Brain Sciences, 2016
Non-invasive system of deep and focused transcranial magnetic stimulation 19th Imeko Tc4 Symposium Measurements of Electrical Quantities 2013 and 17th International Workshop on ADC and DAC Modelling and Testing, 2013
Intraoperative dopamine release during globus pallidus internus stimulation in Parkinson's disease Raquel C.R. Martinez, Clement Hamani, Milene Cristina de Carvalho, Amanda Ribeiro de Oliveira, Eduardo Alho, Jessie Navarro, Maria Gabriela dos Santos Ghilardi, Edson Bor‐Seng‐Shu, Helmut Heinsen, José Pinhata Otoch, Marcus Lira Brandão, Egberto Reis Barbosa, Manoel Jacobsen Teixeira, Erich Talamoni Fonoff Movement Disorders, 2013
Ozone therapy as a treatment for low back pain secondary to herniated disc: A systematic review and meta-analysis of randomized controlled trials International Journal of Ozone Therapy, 2012
Ozone therapy as a treatment for low back pain secondary to herniated disc: A systematic review and meta-analysis of randomized controlled trials Pain Physician, 2012
Cerebral hemodynamics: Concepts of clinical importance Edson Bor-Seng-Shu, William S. Kita, Eberval G. Figueiredo, Wellingson S. Paiva, Erich T. Fonoff, Manoel J. Teixeira, Ronney B. Panerai Arquivos De Neuro Psiquiatria, 2012
Clinically nonfunctioning pituitary adenoma growth after radiosurgery Rafael Loch Batista, Andrea Cecilia Toscanini, Andrea Glezer, Mário Gilberto Siqueira, Salomon Benabou, Erick Talamoni Fonoff, Wagner Malagó Tavares, Manoel Jacobsen Teixeira, Malebranche Berardo Carneiro da Cunha Neto Arquivos De Neuro Psiquiatria, 2012
Psychometric validation of the Portuguese version of the Neuropathic Pain Symptoms Inventory Daniel de Andrade, Karine ASL Ferreira, Carine M Nishimura, Lyn T Yeng, Abrahão F Batista, Katia de Sá, Joaci Araujo, Patrick RNAG Stump, Helena H Kaziyama, Ricardo Galhardoni, Erich T Fonoff, Gerson Ballester, Telma Zakka, Didier Bouhassira, Manoel J Teixeira Health and Quality of Life Outcomes, 2011
Use of intraoperative MRI for resection of gliomas. Hector Navarro Cabrera, Antonio Nogueira de Almeida, Clemar Corrêa da Silva, Erich Talamoni Fonoff, Maria das Graças Martin, Claudia da Costa Leite, Manoel Jacobsen Teixeira Arquivos De Neuro Psiquiatria, 2011
Wavelet transform and cross-correlation as tools for seizure prediction Claudia C. Botero Suarez, Erich Talamoni Fonoff, Mario Alonso Munoz G, Antonio Carlos Godoi, Gerson Ballester, Francisco Javier Ramirez-Fernandez 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology Society Embc 10, 2010
Paracoccidioidomycosis: Intralesional therapy Manoel Jacobsen Teixeira, Erich Talamoni Fonoff, Luís dos Ramos Machado, José Paulo Smith Nóbrega, Hugo Sterman-Neto, Robson Luis Oliveira de Amorim Arquivos De Neuro Psiquiatria, 2010
Nelson's syndrome: A case report Priscilla Cukier, Flávia Moretti Duch, Manoel Jacobsen Teixeira, Maria Candida B.V. Fragoso, Maria Adelaide A. Pereira, Daniel Soares Freire, Erich Talamoni Fonoff, Márcia Helena Soares Costa, Sorahia Domenice, Antonio Marmo Lucon, Berenice B. de Mendonça Arquivos Brasileiros De Endocrinologia E Metabologia, 2007
